News | March 23, 2026
Zydus launches affordable Semaglutide in India after patent expiry
Targets diabetes & obesity crisis as India grapples with soaring metabolic disorders
Targets diabetes & obesity crisis as India grapples with soaring metabolic disorders
This follows a $6 million expansion in Rosenberg in 2025 and signals a major push to boost commercial capacity, expand R&D capabilities, and meet rising demand for US-based drug product manufacturing
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
AstraZeneca says the approval strengthens its push to bring immunotherapy earlier into cancer treatment, where long-term cures are possible
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
Remidex manufactures micronutrient premixes and nutraceuticals,
The protections extend through at least 2035, with the potential for further extensions
The Phase 1 dose-escalation trial enrolled 25 evaluable patients and was designed to determine the recommended dose of LYMPHIR
Subscribe To Our Newsletter & Stay Updated
